You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis
|
|---|---|
| Published in |
Frontiers in oncology, October 2017
|
| DOI | 10.3389/fonc.2017.00248 |
| Pubmed ID | |
| Authors |
Kylie L. Gorringe, Stephen B. Fox |
| Abstract |
Ductal carcinoma in situ (DCIS) is an often-diagnosed breast disease and a known, non-obligate, precursor to invasive breast carcinoma. In this review, we explore the clinical and pathological features of DCIS, fundamental elements of DCIS biology including gene expression and genetic events, the relationship of DCIS with recurrence and invasive breast cancer, and the interaction of DCIS with the microenvironment. We also survey how these various elements are being used to solve the clinical conundrum of how to optimally treat a disease that has potential to progress, and yet is also likely over-treated in a significant proportion of cases. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Italy | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 184 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 184 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 26 | 14% |
| Student > Master | 26 | 14% |
| Student > Bachelor | 19 | 10% |
| Researcher | 17 | 9% |
| Other | 12 | 7% |
| Other | 21 | 11% |
| Unknown | 63 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 39 | 21% |
| Biochemistry, Genetics and Molecular Biology | 30 | 16% |
| Agricultural and Biological Sciences | 17 | 9% |
| Nursing and Health Professions | 9 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 3% |
| Other | 19 | 10% |
| Unknown | 65 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 November 2022.
All research outputs
#8,083,151
of 25,998,826 outputs
Outputs from Frontiers in oncology
#2,882
of 22,783 outputs
Outputs of similar age
#121,150
of 342,315 outputs
Outputs of similar age from Frontiers in oncology
#25
of 96 outputs
Altmetric has tracked 25,998,826 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 22,783 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 342,315 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 96 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.